Crown Reserve Acquisition Corp. I (CRAC) announced a Business Combination Agreement with Carvix, Inc. on March 30, 2026, which will result in Carvix becoming a wholly-owned subsidiary of CRAC. Carvix stockholders are set to receive 50,000,001 shares at closing, with potential earnout shares up to 50,000,100 based on future performance targets. For the three months ended March 31, 2026, CRAC reported a net loss of $(263,493), while its Trust Account balance grew to $174,928,579. The company also disclosed substantial doubt about its ability to continue as a going concern if the business combination is not completed by the extended deadline of February 10, 2027.
